drugset / Trial / NCT06484439

Controlled Trial to Determine Most Effective Post-Operative Analgesia After Third Molar Extraction

NCT06484439

Phase 0 Completed 80 enrolled United States Naval Medical Center, San Diego
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a prospective randomized clinical trial that will investigate which post-operative medications in conjunction with a multimodal analgesia approach can most effectively control post-operative pain and reduce opioid consumption.

Timeline

Start
2018-02-14
Primary completion
2021-11-03
Completion
2021-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocodone Unknown 5 mg Oral
Comparator Ibuprofen Small molecule 600 mg Oral
Subject Ketorolac Other / unclassified 10 mg Oral
Subject Oxycodone Other / unclassified 5 mg Oral
Background Acetaminophen Small molecule 650 mg Oral